For nonpreferred filgrastim products, submit prior authorization requests using NovoLogix^® starting in April

For courses of treatment that start on or after April 1, 2021, you’ll need to submit prior authorization requests for all members for nonpreferred filgrastim products using the NovoLogix^® online tool.

As we’ve communicated previously, for courses of treatment that started Oct. 1, 2020, through March 31, 2021, you should submit requests to AIM Specialty Health^® for Blue Care Network commercial, Medicare Plus Blue℠ and BCN Advantage℠ members. And for Blue Cross Blue Shield of Michigan fully insured commercial members, for courses of treatment that started on or after Oct. 1, 2020, you’re already submitting these requests using NovoLogix so nothing will change.

Note: For commercial members, these requirements:

• Apply only to groups that participate in the standard commercial Medical Drug Prior Authorization Program for drugs covered under the medical benefit
• Do not apply to members covered by the Blue Cross and Blue Shield Federal Employee Program^®, the Michigan Education Special Services Association or UAW Retiree Medical Benefits Trust non-Medicare members

For details on the preferred and nonpreferred filgrastim products, refer to the August 2020 Record article.

As a reminder, authorization isn’t a guarantee of payment. Health care practitioners need to verify eligibility and benefits for members.